Kuwait Life Sciences Company

Kuwait Life Sciences Company (KLSC) is a private investment firm established in 2010, focusing on healthcare innovation in the Middle East and North Africa (MENA) region. Fully owned by the National Technology Enterprises Company (NTEC), KLSC aims to advance healthcare services and systems by investing in life sciences and medical technology sectors. The firm operates in healthcare investment, life sciences training, medical technology, and pharmaceutical distribution, supporting both public and private sector stakeholders to access emerging technologies and establish unique projects. KLSC's investment strategy encompasses three main pillars: incubation of local and regional startup projects, international venture capital, and regional and international private equity. The firm invests in equity partnerships with private sector entrepreneurs or companies, favoring joint ventures that add value and meet local or regional demand. KLSC has developed unique projects such as the Life Sciences Academy, Innomedics, and NewBridge, and has invested in companies like Quanta Fluid Solutions, Supersonic Imagine, Median Technologies, Clinart, and eCore. With a paid-up capital of 15 million Kuwait Dinars (approximately $53 million USD), KLSC is considered one of the pioneering venture capital and private equity firms in the MENA region, investing globally and operating regionally to advance healthcare services and systems within the region.

Focus on healthcare innovation, Targeting MENA region, Preference for joint ventures, Interest in life sciences and medical technology sectors, Support for both public and private sector stakeholders